Moreover, OPTN recruitment was not affected by two ALS-causative TBK1 mutants, E696K and ∆690-713, indicating that gefitinib increases the phosphorylation and activation of OPTN independently of TBK1 kinase (Fig. 6e–g). This evidence concerns the gene TBK1 and amyotrophic lateral sclerosis.